NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-07: Reporting owner Burbank Jeffrey H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-07: Reporting owner Swan Winifred L; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-07: Reporting owner Brown Robert; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-07: Reporting owner Webb Michael J.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-07 | Burbank Jeffrey H Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +120,000 120,000 owned after | $14.44 exercise price | 2007-12-11 | |
| 2007-12-07 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $14.44 exercise price | 2007-12-11 | |
| 2007-12-07 | Brown Robert Officer (Sr. Vice President, CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $14.44 exercise price | 2007-12-11 | |
| 2007-12-07 | Webb Michael J. Officer (SVP Quality Assurance) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $14.44 exercise price | 2007-12-11 | |
| 2007-12-07 | Turk Joseph E Jr Officer (SVP Commercial Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $14.44 exercise price | 2007-12-11 | |
| 2007-10-01 | Azel Augustin Officer (Senior VP, Manufacturing) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +97,009 97,009 owned after | $14.98 exercise price | 2007-10-03 | |
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.47 exercise price | 2007-08-20 | ||
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.10 exercise price | 2007-08-20 | ||
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $8.55 exercise price | 2007-08-20 | ||
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.76 exercise price | 2007-08-20 | ||
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.84 exercise price | 2007-08-20 | ||
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.10 exercise price | 2007-08-20 | ||
| 2007-08-20 holding as of filing | Webb Michael J. Officer (SVP Quality Assurance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $8.15 exercise price | 2007-08-20 | ||
| 2007-08-16 | Webb Michael J. Officer (SVP Quality Assurance) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 159,219 owned after | $13.54 exercise price | 2007-08-20 | |
| 2007-05-30 | Utterberg David S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 | |
| 2007-05-30 | PHILDIUS PETER P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 | |
| 2007-05-30 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 | |
| 2007-05-30 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 | |
| 2007-05-30 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 | |
| 2007-05-30 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 | |
| 2007-05-30 | CHAMBON PHILIPPE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $12.20 exercise price | 2007-06-01 |